fenofibrate  
Worldwide
 
Overview
 

Latest News

ANI Pharmaceuticals Reports Record Second Quarter Results and Increases Full-year 2016 Guidance
ANI Pharmaceuticals (August 04, 2016)
Amarin Reports Second Quarter 2016 Financial Results and Provides Update on Operations
Amarin (August 04, 2016)
Consolidated Financial Results for Fiscal 2016
Kaken Pharmaceutical (August 03, 2016)

Displaying 3 out of a possible 636 unique stories.
Results Sorted By date


EvaluatePharma® - the premier source for pharma and biotech analysis.

Expert integration of financial and product data across historic and forecast timeframes (1986 to 2018) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, patent status, deals, license revenues and much more.

Summary Generic Name Information

Generic Name: fenofibrate
Therapeutic Subcategory:     Anti-hyperlipidaemics

Evaluate - intelligence you can act on

Evaluate delivers market intelligence with standardized, transparent, integrated data that clients rely on.

Choose from a vast array of dynamic reports, customize, edit and download to PDF, Excel or create bespoke reports with expert client support.

Explore Content & Tools

Welcome

Evaluate provides market intelligence and analysis for the pharma, biotech and medtech industries.

Explore Evaluate


Register to access more FREE content:

  • 2011 Product Sales analysis
  • Download to Excel
  • Search 2 yrs of company press releases

Register for Free Analysis

Register to access more free insights and analysis from Evaluate.  

Register Now